Renner Niklas, Wirth Stephan Hermann, Osterhoff Georg, Böni Thomas, Berli Martin
Orthopädische Klinik Luzern AG, Hirslanden Klinik St.Anna, Luzern, Switzerland.
Department of Orthopedics, University of Zürich, Balgrist University Hospital, Zürich, Switzerland.
BMC Musculoskelet Disord. 2016 Dec 29;17(1):504. doi: 10.1186/s12891-016-1357-4.
Charcot neuropathic arthropathy (CN) is a chronic, progressive, destructive, non-infectious process that most frequently affects the bone architecture of the foot in patients with sensory neuropathy. We evaluated the outcome of protected weightbearing treatment of CN in unilaterally and bilaterally affected patients and secondarily compared outcomes in protected versus unprotected weightbearing treatment.
Patient records and radiographs from 2002 to 2012 were retrospectively analyzed. Patients with Type 1 or Type 2 diabetes with peripheral neuropathy were included. Exclusion criteria included immunosuppressive or osteoactive medication and the presence of bone tumors. Ninety patients (101 ft), mean age 60.7 ± 10.6 years at first diagnosis of CN, were identified. Protected weightbearing treatment was achieved by total contact cast or custom-made orthosis. Ulcer, infection, CN recurrence, and amputation rates were recorded. Mean follow-up was 48 (range 1-208) months.
Per the Eichenholtz classification, 9 ft were prodromal, 61 in stage 1 (development), 21 in stage 2 (coalescence) and 10 in stage 3 (reconstruction). Duration of protected weightbearing was 20 ± 21 weeks and 22 ± 29 weeks in patients with unilateral and bilateral CN, respectively. In bilaterally affected patients, new ulcers developed in 9/22 (41%) feet. In unilaterally affected patients, new ulcers developed in 5/66 (8%) protected weightbearing feet and 4/13 (31%) unprotected, full weightbearing feet (p = 0.036). The ulceration rate was significantly higher in bilaterally versus unilaterally affected patients with a protected weightbearing regimen (p = 0.004). Soft tissue infection occurred in 1/13 (8%) unprotected weightbearing feet and 1/66 (2%) protected weightbearing feet in unilaterally affected patients, and in 1/22 (4%) protected weightbearing feet of bilaterally affected patients. Recurrence and amputation rates were similar across treatment modalities.
Bilateral CN results in significantly more ulcers than unilateral CN and leads to slightly higher soft tissue infections. Protected weightbearing in an orthopedic device can reduce the risk for complications in acute CN of the foot and ankle.
夏科氏神经关节病(CN)是一种慢性、进行性、破坏性的非感染性疾病,最常影响感觉神经病变患者足部的骨骼结构。我们评估了单侧和双侧受累患者采用保护性负重治疗CN的结果,并对保护性负重治疗与非保护性负重治疗的结果进行了二次比较。
回顾性分析2002年至2012年的患者记录和X线片。纳入1型或2型糖尿病伴周围神经病变的患者。排除标准包括免疫抑制或骨活性药物以及存在骨肿瘤。共确定90例患者(101只足),首次诊断CN时的平均年龄为60.7±10.6岁。通过全接触石膏或定制矫形器实现保护性负重治疗。记录溃疡、感染、CN复发和截肢率。平均随访时间为48(范围1 - 208)个月。
根据艾兴霍尔茨分类,9只足处于前驱期,61只足处于1期(发展期),21只足处于2期(融合期),10只足处于3期(重建期)。单侧和双侧CN患者的保护性负重持续时间分别为20±21周和22±29周。在双侧受累患者中,9/22(41%)只足出现新溃疡。在单侧受累患者中,5/66(8%)只接受保护性负重的足和4/13(31%)只非保护性、完全负重的足出现新溃疡(p = 0.036)。在采用保护性负重方案的情况下,双侧受累患者的溃疡发生率显著高于单侧受累患者(p = 0.004)。在单侧受累患者中,1/13(8%)只非保护性负重的足和1/66(2%)只保护性负重的足发生软组织感染,在双侧受累患者中,1/22(4%)只保护性负重的足发生软组织感染。不同治疗方式的复发率和截肢率相似。
双侧CN导致的溃疡明显多于单侧CN,软组织感染率略高。使用矫形器械进行保护性负重可降低足踝急性CN并发症的风险。